MedPath

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

Phase 4
Completed
Conditions
Sexual Dysfunction
Endothelial Dysfunction
Quality of Life
Inflammation
Interventions
Behavioral: Exercise and diet
Registration Number
NCT01554735
Lead Sponsor
Changi General Hospital
Brief Summary

This study aims to evaluate the extent to which weight loss of 5-10% from baseline, induced by exercise and diet, improves metabolic and inflammatory profile, endothelial function, erectile function, sexual desire, lower urinary tract symptoms (LUTS), and quality of life in obese men.

Detailed Description

This study aims to evaluate the extent to which weight loss of 5-10% from baseline, induced by exercise and diet, improves metabolic and inflammatory profile, endothelial function, erectile function, sexual desire, lower urinary tract symptoms (LUTS), and quality of life in obese men.Men aged 30-65 years, with body mass index (BMI) ≥ 27.5 kg/m2, will be recruited from referrals to the Sports Medicine Centre in Changi General Hospital. The study will be conducted at the Sports Medicine Centre by trained medical investigators, dieticians and sports trainers.At baseline, 12 and 24 weeks, fasting glucose and lipids, insulin, testosterone, sex-hormone binding globulin, serum C-reactive protein and interleukin-6 are measured, endothelial function is measured by the non-invasive EndoPAT method, and validated questionnaires administered to assess changes in erectile function, sexual desire, LUTS and quality of life

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
70
Inclusion Criteria
  • Male, aged 30-65 years
  • Body Mass Index (BMI) >/= 27.5 kg/m2
  • Waist circumference (WC) >/= 90 cm
Exclusion Criteria
  • pituitary disease or cranial radiotherapy
  • previous or current androgen replacement or deprivation therapy
  • current treatment for sexual problems or LUTS
  • glomerular filtration rate < 60 ml/min
  • liver disease
  • alcohol intake exceeding 500 g/week in the previous 12 months
  • use of opiates, glucocorticoids, recreational drugs or phosphodiesterase inhibitors

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
lifestyle counsellingExercise and dietexercise and diet counselling for weight loss
Primary Outcome Measures
NameTimeMethod
erectile function24 weeks

Increase in IIEF-5 score

Secondary Outcome Measures
NameTimeMethod
lower urinary tract symptoms24 weeks

decrease in IPSS score

Trial Locations

Locations (1)

Changi General Hospital

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath